Tiverton Asset Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Tiverton Asset Management’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,531	Closed	-$4.26M	–	169
2016 Q2	$4.26M	Sell	4,531 -36,476	-89%	-$165K	0.18%	115
2016 Q1	$231K	Sell	41,007 -8,993	-18%	-$117K	0.01%	158
2015 Q4	$860K	Sell	50,000 -10,000	-17%	-$238K	0.03%	139
2015 Q3	$1.27M	Sell	60,000 -10,000	-14%	-$343K	0.03%	147
2015 Q2	$3.46M	Hold	70,000	–	–	0.07%	140
2015 Q1	$5.48M	Hold	70,000	–	–	0.11%	118
2014 Q4	$4.24M	Hold	70,000	–	–	0.09%	120
2014 Q3	$2.98M	Hold	70,000	–	–	0.07%	119
2014 Q2	$4.33M	Hold	70,000	–	–	0.1%	110
2014 Q1	$4.55M	Hold	70,000	–	–	0.1%	113
2013 Q4	$3.94M	Hold	70,000	–	–	0.09%	107
2013 Q3	$4.29M	Hold	70,000	–	–	0.1%	104
2013 Q2	$4.09M	Buy	+70,000	New	+$4.31M	0.11%	101

Other funds holding OREX

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Samlyn Capital New York $5.82B AUM 36.3% 1-Year Est. Return

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return